Combined Application of Nivolumab and Intravesical Bacillus Calmette-Guérin Led to Acute-Onset Type 1 Diabetes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Combined Application of Nivolumab and Intravesical Bacillus Calmette-Guérin Led to Acute-Onset Type 1 Diabetes ; volume:12 ; number:2 ; year:2019 ; pages:430-433
Case reports in oncology ; 12, Heft 2 (2019), 430-433
- Creator
-
Fujiu, Koichi
Fukaya, Yasuo
Kamimoto, Masahiro
Miyamoto, Hideaki
Cong, Yue
Suzuki, Hiroyuki
- DOI
-
10.1159/000500978
- URN
-
urn:nbn:de:101:1-2019091200182648552117
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fujiu, Koichi
- Fukaya, Yasuo
- Kamimoto, Masahiro
- Miyamoto, Hideaki
- Cong, Yue
- Suzuki, Hiroyuki
Other Objects (12)
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Guérin therapy: Case report
Durch Bacillus Calmette-Guerin induzierte Tuberkulose
Assessing treatment response after intravesical bacillus Calmette–Guerin induction cycle: are routine bladder biopsies necessary?
Molecular networks discriminating mouse bladder responses to intravesical bacillus Calmette-Guerin (BCG), LPS, and TNF-α
Poncet’s disease after the intravesical instillation of Bacillus Calmette–Guérin (BCG): a case report
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Bekämpfung der Tuberkulose: Schutzimpfung mit Bacillus Calmette-Guérin (BCG)
Intravesical bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: abridged summary of the Cochrane Review
Granulomatous myocarditis arising from intravesical Bacillus Calmette–Guérin therapy leading to death diagnosed by postmortem examination: a case report
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Guérin therapy: Case report
Durch Bacillus Calmette-Guerin induzierte Tuberkulose
Assessing treatment response after intravesical bacillus Calmette–Guerin induction cycle: are routine bladder biopsies necessary?
Molecular networks discriminating mouse bladder responses to intravesical bacillus Calmette-Guerin (BCG), LPS, and TNF-α
Poncet’s disease after the intravesical instillation of Bacillus Calmette–Guérin (BCG): a case report
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Bekämpfung der Tuberkulose: Schutzimpfung mit Bacillus Calmette-Guérin (BCG)
Intravesical bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: abridged summary of the Cochrane Review
Granulomatous myocarditis arising from intravesical Bacillus Calmette–Guérin therapy leading to death diagnosed by postmortem examination: a case report
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Guérin therapy: Case report
Durch Bacillus Calmette-Guerin induzierte Tuberkulose
Assessing treatment response after intravesical bacillus Calmette–Guerin induction cycle: are routine bladder biopsies necessary?
Molecular networks discriminating mouse bladder responses to intravesical bacillus Calmette-Guerin (BCG), LPS, and TNF-α
Poncet’s disease after the intravesical instillation of Bacillus Calmette–Guérin (BCG): a case report
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Bekämpfung der Tuberkulose: Schutzimpfung mit Bacillus Calmette-Guérin (BCG)
Intravesical bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: abridged summary of the Cochrane Review